These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 26168725

  • 1. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA, Cvoro A, Amato AA, Sieglaff DH, Filgueira CS, Arumanayagam AS, de Lima Mdo C, Pitta IR, de Assis Rocha Neves F, Webb P.
    Biochem Biophys Res Commun; 2015 Aug 28; 464(3):718-23. PubMed ID: 26168725
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
    Kim MK, Chae YN, Choi SH, Moon HS, Son MH, Bae MH, Choi HH, Hur Y, Kim E, Park YH, Park CS, Kim JG, Lim JI, Shin CY.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):673-81. PubMed ID: 20974124
    [Abstract] [Full Text] [Related]

  • 7. Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.
    Tan Y, Muise ES, Dai H, Raubertas R, Wong KK, Thompson GM, Wood HB, Meinke PT, Lum PY, Thompson JR, Berger JP.
    Mol Pharmacol; 2012 Jul 15; 82(1):68-79. PubMed ID: 22496518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY, Wu HS, Tang L, Feng CR, Yu JH, Li Y, Yang YS, Yang B, He QJ.
    Pharmacol Res; 2007 Oct 15; 56(4):335-43. PubMed ID: 17889553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase.
    Kim J, Lee YJ, Kim JM, Lee SY, Bae MA, Ahn JH, Han DC, Kwon BM.
    Int J Biochem Cell Biol; 2016 Dec 15; 81(Pt A):57-66. PubMed ID: 27780754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The DLK gene is a transcriptional target of PPARγ.
    Couture JP, Blouin R.
    Biochem J; 2011 Aug 15; 438(1):93-101. PubMed ID: 21585338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. WSF-7 Inhibits Obesity-Mediated PPARγ Phosphorylation and Improves Insulin Sensitivity in 3T3-L1 Adipocytes.
    Zhang Y, Wang Y, Li X, Gu K, Li M, Zhang Y, Zhang Z, Wang S, Li Z.
    Biol Pharm Bull; 2020 Aug 15; 43(3):526-532. PubMed ID: 32115511
    [Abstract] [Full Text] [Related]

  • 20. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
    Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller A, Kharitonenkov A.
    J Cell Physiol; 2007 Jan 15; 210(1):1-6. PubMed ID: 17063460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.